HEALTHCARE & TECHNOLOGY INTERNATIONAL : revenue, balance sheet and financial ratios

HEALTHCARE & TECHNOLOGY INTERNATIONAL is a French company founded 28 years ago, specialized in the sector Activités des agences de placement de main-d'œuvre . Based in NEUILLY-SUR-SEINE (92200), this company of category PME shows in 2024 a revenue of 1.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - HEALTHCARE & TECHNOLOGY INTERNATIONAL (SIREN 415172709)
Indicator 2024 2023 2021 2020 2019 2018 2017 2016
Revenue 1 812 733 € 2 038 353 € 1 945 336 € 1 346 671 € 1 681 397 € 1 590 862 € 1 054 094 € 1 642 519 €
Net income -149 438 € -150 570 € 80 232 € 25 779 € 187 293 € 1 716 € -278 641 € 17 127 €
EBITDA -137 157 € -148 128 € 92 336 € 35 600 € 212 567 € 13 336 € -280 006 € 58 622 €
Net margin -8.2% -7.4% 4.1% 1.9% 11.1% 0.1% -26.4% 1.0%

Revenue and income statement

In 2024, HEALTHCARE & TECHNOLOGY INTERNATIONAL achieves revenue of 1.8 M€. Revenue is growing positively over 8 years (CAGR: +1.2%). Significant drop of -11% vs 2023. After deducting consumption (0 €), gross margin stands at 1.8 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -137 k€, representing -7.6% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -149 k€ (-8.2% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 812 733 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 812 733 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-137 157 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-150 648 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-149 438 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-7.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.656%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

43.53%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-8.208%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-0.301

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

7.4%

Solvency indicators evolution
HEALTHCARE & TECHNOLOGY INTERNATIONAL

Sector positioning

Debt ratio
13.66 2024
2021
2023
2024
Q1: 0.0
Med: 2.18
Q3: 26.9
Average -11 pts over 3 years

In 2024, the debt ratio of HEALTHCARE & TECHNOLOGY I... (13.66) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
43.53% 2024
2021
2023
2024
Q1: 5.01%
Med: 27.87%
Q3: 56.01%
Good

In 2024, the financial autonomy of HEALTHCARE & TECHNOLOGY I... (43.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-0.3 years 2024
2021
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.47 years
Excellent -50 pts over 3 years

In 2024, the repayment capacity of HEALTHCARE & TECHNOLOGY I... (-0.30) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 187.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

187.409

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-1.204

Liquidity indicators evolution
HEALTHCARE & TECHNOLOGY INTERNATIONAL

Sector positioning

Liquidity ratio
187.41 2024
2021
2023
2024
Q1: 118.87
Med: 185.54
Q3: 314.49
Good -13 pts over 3 years

In 2024, the liquidity ratio of HEALTHCARE & TECHNOLOGY I... (187.41) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-1.2x 2024
2021
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 0.55x
Watch

In 2024, the interest coverage of HEALTHCARE & TECHNOLOGY I... (-1.2x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 48 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 5 days. The gap of 43 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. WCR is negative (-7 days): operations structurally generate cash. Notable WCR improvement over the period (-124%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-34 823 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

48 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

5 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-7 j

WCR and payment terms evolution
HEALTHCARE & TECHNOLOGY INTERNATIONAL

Positioning of HEALTHCARE & TECHNOLOGY INTERNATIONAL in its sector

Comparison with sector Activités des agences de placement de main-d'œuvre

Valuation estimate

Based on 147 transactions of similar company sales (all years), the value of HEALTHCARE & TECHNOLOGY INTERNATIONAL is estimated at 145 150 € (range 109 456€ - 249 316€). The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
147 transactions
109k€ 145k€ 249k€
145 150 € Range: 109 456€ - 249 316€
Section all-time Aggregated at NAF section level

Valuation method used

Revenue Multiple
1 812 733 € × 0.08x = 145 150 €
Range: 109 457€ - 249 317€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 147 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des agences de placement de main-d'œuvre )

Compare HEALTHCARE & TECHNOLOGY INTERNATIONAL with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des agences de placement de main-d'œuvre

Frequently asked questions about HEALTHCARE & TECHNOLOGY INTERNATIONAL

What is the revenue of HEALTHCARE & TECHNOLOGY INTERNATIONAL ?

The revenue of HEALTHCARE & TECHNOLOGY INTERNATIONAL in 2024 is 1.8 M€.

Is HEALTHCARE & TECHNOLOGY INTERNATIONAL profitable?

HEALTHCARE & TECHNOLOGY INTERNATIONAL recorded a net loss in 2024.

Where is the headquarters of HEALTHCARE & TECHNOLOGY INTERNATIONAL ?

The headquarters of HEALTHCARE & TECHNOLOGY INTERNATIONAL is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of HEALTHCARE & TECHNOLOGY INTERNATIONAL ?

The tax return of HEALTHCARE & TECHNOLOGY INTERNATIONAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does HEALTHCARE & TECHNOLOGY INTERNATIONAL operate?

HEALTHCARE & TECHNOLOGY INTERNATIONAL operates in the sector Activités des agences de placement de main-d'œuvre (NAF code 78.10Z). See the 'Sector positioning' section above to compare the company with its competitors.